EMEA-000311-PIP01-08-M04

Key facts

Invented name
Stelara
Active substance
Ustekinumab
Therapeutic area
Immunology-Rheumatology-Transplantation
Decision number
P/0003/2016
PIP number
EMEA-000311-PIP01-08-M04
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of chronic plaque psoriasis
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Janssen-Cilag International NV
Belgium
E-mail: mojanen@its.jnj.com
Tel. +34 917228079
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating